Prostate cancer: a chronic illness.
Prostate cancer is the most frequently diagnosed malignancy and the second-leading cause of cancer death in men. The 10-year survival rate for all stages of prostate cancer is 93%. Men with prostate cancer live with the disease for many years, and the side effects of the disease and treatments have physical and psychosocial implications for the patient, spouse, and family. This case study explores the evolution of a patient with prostate cancer, from time of diagnosis through treatment decision making and ultimately end of life. Discussion of the implications for practice and research is included.
Gallo Prostate Cancer Center, Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. smd9@columbia.edu
Susan
S
Doyle-Lindrud
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D002908:Chronic Disease; D000529:Complementary Therapies; D003657:Decision Making; D018450:Disease Progression; D005190:Family / Q000523:psychology; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010348:Patient Care Team; D010353:Patient Education as Topic; D010358:Patient Participation; D017430:Prostate-Specific Antigen; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D013727:Terminal Care
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen